BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2024 9:30:52 AM | Browse: 176 | Download: 613
 |
Received |
|
2024-09-19 14:09 |
|
Peer-Review Started |
|
2024-09-19 14:09 |
|
First Decision by Editorial Office Director |
|
2024-09-30 10:28 |
|
Return for Revision |
|
2024-09-30 10:28 |
|
Revised |
|
2024-10-07 08:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-31 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-31 11:10 |
|
Articles in Press |
|
2024-10-31 11:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-06 02:47 |
|
Publish the Manuscript Online |
|
2024-12-12 09:30 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Network pharmacology: Changes the treatment mode of "one disease-one target" in cancer treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shuai Liu and Yong-Wei Yu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yong-Wei Yu, PhD, Department of Critical Care Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310000, Zhejiang Province, China. yuyongwei@zju.edu.cn |
| Key Words |
Network pharmacology; Cancer; Multicomponent; Multitarget; Therapy |
| Core Tip |
Cancer cannot be effectively treated against a single gene target because it involves the synergy of different gene groups. Network pharmacology provides strong evidence of "multicomponent-multitarget" synergistic effects for the treatment of cancer with Chinese medicine. |
| Publish Date |
2024-12-12 09:30 |
| Citation |
Liu S, Yu YW. Network pharmacology: Changes the treatment mode of "one disease-one target" in cancer treatment. World J Gastrointest Oncol 2025; 17(1): 101581 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i1/101581.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i1.101581 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
